Chiropractors in Dell Rapids, SD Accepting Medicare
8 Chiropractors found. Showing 1 - 8
 Danika Lee Nachreiner, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 410 W 4th Street, Dell Rapids, SD 57022 Phone: 605-334-6656 Fax: 605-271-7616 |
 Dr. Jeffery Todd Henry, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 713 E 8th St, Dell Rapids, SD 57022 Phone: 605-428-4044 |
 Chirosport Dell Rapids Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 410 W 4th St, Dell Rapids, SD 57022 Phone: 605-334-6656 Fax: 605-271-7616 |
Patrick William Harrington, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 507 N Hwy 77, Ste C, Dell Rapids, SD 57022 Phone: 605-428-4444 Fax: 605-428-4458 |
Harrington Chiropractic Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 507 N Highway 77, Ste C, Dell Rapids, SD 57022 Phone: 605-428-4444 Fax: 605-428-4458 |
Alex Nachreiner, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 410 W 4th St, Dell Rapids, SD 57022 Phone: 605-334-6656 Fax: 605-271-7616 |
Dr. Seth Allen Severtson, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 513 W 4th St, Dell Rapids, SD 57022 Phone: 605-428-4778 |
Severtson Spinal Care Chiropractor Medicare: Medicare Enrolled Practice Location: 513 W 4th St, Dell Rapids, SD 57022 Phone: 605-428-4778 |
News Archive
BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy
BioDelivery Sciences International, Inc. announced today the enrollment of the first patient in the RHAPSODY Study, a Phase 3 clinical trial of Clonidine Topical Gel for the treatment of painful diabetic neuropathy.
VIVUS' Phase 3 studies find Qnexa effective in tackling obesity
VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from two final, phase 3 pivotal 56-week studies, EQUIP (OB-302) and CONQUER (OB-303), evaluating the safety and efficacy of Qnexa(TM), an investigational drug, in more than 3,750 patients across 93 sites. The EQUIP and CONQUER studies met all primary endpoints by demonstrating statistically significant weight loss with all three doses of Qnexa, as compared to placebo.
Maryland Proton Treatment Center completes first patient treatment with Varian ProBeam system
Varian Medical Systems, today announced the Maryland Proton Treatment Center successfully completed its first patient treatment with the Varian ProBeam system. The MPTC at the University of Maryland BioPark in West Baltimore houses five treatment rooms and is the first in the Eastern US to offer image-guided intensity-modulated proton therapy (IMPT) with a ProBeam system.
USAID report highlights need for better water management in agriculture
"With its recently released Water and Development Strategy, USAID highlights some practical and potentially powerful initiatives both to improve health by expanding access to clean water and sanitation and to improve food security through better water management in agriculture," Isobel Coleman, a senior fellow for U.S. foreign policy and director of the Civil Society, Markets, and Democracy Initiative at the Council on Foreign Relations, writes in the council's "Democracy in Development" blog.
Alpha Pro Tech changes distribution strategy for disposable protective apparel
Alpha Pro Tech, Ltd. a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced a strategic change in the Company's disposable protective apparel distribution strategy.
› Verified 6 days ago
Chiropractors
Speech-Language Pathologists
Physical Therapists
Podiatrists
Optometrists